Overview

Alpha-1 Blockade for Alcohol Use Disorder (AUD)

Status:
Recruiting

Trial end date:
2024-12-20

Target enrollment:

Participant gender:

Summary

The goal of this research is to replicate findings previously conducted in a pilot trial and to understand, mechanistically, the role of stress in the development of AUD pharmacotherapies that target noradrenergic blockade.

Phase:

Phase 2

Details

Lead Sponsor:

Brown University

Treatments:

Doxazosin